Sage Rhino Capital’s Medtronic MDT Stock Holding History

Sage Rhino Capital’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-2,296	Closed	-$206K	–	199
2022 Q2	$206K	Sell	2,296 -365	-14%	-$37K	0.08%	178
2022 Q1	$295K	Sell	2,661 -265	-9%	-$28K	0.09%	166
2021 Q4	$303K	Sell	2,926 -215	-7%	-$24.9K	0.08%	163
2021 Q3	$394K	Sell	3,141 -5	-0.2%	-$647	0.12%	127
2021 Q2	$391K	Buy	3,146 +49	+2%	+$6.15K	0.12%	132
2021 Q1	$366K	Buy	3,097 +14	+0.5%	+$1.64K	0.12%	122
2020 Q4	$361K	Buy	3,083 +49	+2%	+$5.39K	0.14%	112
2020 Q3	$315K	Buy	3,034 +8	+0.3%	+$803	0.15%	109
2020 Q2	$277K	Buy	3,026 +78	+3%	+$7.48K	0.15%	119
2020 Q1	$266K	Sell	2,948 -64	-2%	-$6.81K	0.19%	98
2019 Q4	$357K	Buy	3,012 +76	+3%	+$8.34K	0.2%	103
2019 Q3	$319K	Buy	2,936 +18	+0.6%	+$1.88K	0.2%	98
2019 Q2	$284K	Sell	2,918 -16	-0.5%	-$1.46K	0.18%	105
2019 Q1	$267K	Buy	+2,934	New	+$263K	0.18%	101

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Sage Rhino Capital's MDT Position: Q3 2022 in Review

Sage Rhino Capital sold out of Medtronic (MDT) in Q3 2022, closing a stake of 2,296 shares — an estimated $206K sold.

Sage Rhino Capital first reported a position in MDT in Q1 2019 and held it in 14 quarters. The position peaked at $394K in Q3 2021. 1,931 funds tracked by Wall St. Rank hold MDT as of Q3 2022.

Sage Rhino Capital reported no remaining Medtronic position as of Q3 2022 after selling out during the quarter.
Sage Rhino Capital sold 2,296 Medtronic shares in Q3 2022, an estimated $206K.
Sage Rhino Capital first reported a position in Medtronic in Q1 2019 and held it in 14 quarters.
Sage Rhino Capital's Medtronic position peaked at $394K in Q3 2021.
1,931 funds tracked by Wall St. Rank held Medtronic as of Q3 2022.

Based on Sage Rhino Capital's 13F filing for Q3 2022, filed 24 Oct 2022.